Epstein-Barr Virus-Associated Lymphoproliferative Disease During Imatinib Mesylate Treatment for Chronic Myeloid Leukemia
Haematologica - Italy
doi 10.3324/haematol.2019.217141
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 11, 2019
Authors
Publisher
Ferrata Storti Foundation (Haematologica)